Tunable Nanopillar Electrodes for Label-Free DNA Sequencing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current DNA sequencing technologies are costly, time-consuming, and lack reproducibility and scalability for rapid analysis of millions of DNA molecules, particularly in precision medicine applications, due to reliance on optical methods and complex fluorescent labeling.
Innovation Solution
The development of dimension-tunable nanoelectrode structures using vertical nanopillars or horizontal nanoelectrodes that allow for label-free DNA genome analysis, enabling scalable and cost-effective sequencing by measuring electronic signal changes without the need for fluorescent labeling.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If optical methods with fluorescent labeling are used for DNA sequencing, then sequencing capability is achieved, but cost and time consumption increase significantly
Solution Approach 1:
The patent replaces optical detection methods with electronic detection methods. Specifically, it substitutes fluorescent labeling and optical imaging systems with electronic sensors and electrical signal detection systems. This substitution eliminates the need for complex optical components, fluorescent dyes, and associated imaging infrastructure, thereby dramatically reducing both cost and time while maintaining sequencing capability through direct electronic measurement of DNA molecules.
2Measurement precision
If optical methods with fluorescent labeling are used for DNA sequencing, then sequencing capability is achieved, but device complexity increases
Solution Approach 1:
The patent replaces complex optical systems with simpler electronic systems. Instead of requiring fluorescent labels, optical excitation sources, filters, and imaging systems, the invention uses straightforward electronic sensors that detect electrical signals generated by DNA molecules. This substitution dramatically simplifies the overall device architecture while maintaining sequencing functionality.
3Measurement precision
If conventional sequencing platforms are used, then genome sequencing is achieved, but scalability for millions of DNA molecules is limited
Solution Approach 1:
The patent divides the sequencing task into numerous independent parallel measurement channels. Each electronic sensor can independently detect individual DNA molecules, allowing millions of sequencing reactions to occur simultaneously in a massively parallel fashion. This segmentation approach enables linear scaling of productivity by simply increasing the number of sensors, unlike optical methods where increasing parallelism requires proportionally increasing optical complexity and cost.
4Measurement precision
If conventional sequencing platforms are used, then genome sequencing is achieved, but cost effectiveness decreases
Solution Approach 1:
The patent replaces expensive optical components with inexpensive electronic components. Electronic sensors, signal amplification circuits, and data processing systems are significantly cheaper than their optical counterparts, including lasers, fluorescent dyes, filters, and high-resolution imaging systems. This substitution maintains sequencing accuracy while reducing instrument cost from millions to potentially thousands of dollars, dramatically improving cost-effectiveness.
Data Source
AI summary
New methods in nanolithography provide nanoscale structures usable in molecular electronic sensors, such as for nucleotide sequencing. In various embodiments, tunable nanopillars are grown in holes nanopatterned in a resist layer over pairs of electrodes, with the resulting nanopillars acting as vertical extensions of the electrodes buried underneath the resist layer. Exposed top surfaces of the nanopillars are limited in size, thus providing controlled binding of a single or at most just a few bridge molecules between nanopillars in a pair of nanopillars.